NCT06246903View on ClinicalTrials.gov

INTER-PATHOLOGIST READER STUDY

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

August 1, 2024

Conditions
Nevi, Dysplastic
Trial Locations (1)

84132

University of Utah Hospital, Pathology, Salt Lake City

Sponsors

Lead Sponsor

Orlucent, Inc
All Listed Sponsors
lead

Orlucent, Inc

INDUSTRY

NCT06246903 - INTER-PATHOLOGIST READER STUDY | Biotech Hunter | Biotech Hunter